Preprocedural mouthwashes for infection control in dentistry—an update
Objectives
Aerosols and splatter are routinely generated in dental practice and can be contaminated by potentially harmful bacteria or viruses such as SARS-CoV-2. Therefore, preprocedural mouthwashes containing antiseptic agents have been proposed as a potential measure for infection control in dental practice. This review article aims to summarize the clinical (and, if insufficient, preclinical) evidence on preprocedural mouthwashes containing antiseptic agents and to draw conclusions for dental practitioners.
Methods
Literature on preprocedural mouthwashes for reduction of bacterial or viral load in dental aerosols was searched and summarized.
Results
Preprocedural mouthwashes, particularly those containing chlorhexidine digluconate (CHX), cetylpyridinium chloride (CPC), or essential oils (EO), can significantly reduce the bacterial load in dental aerosols. With respect to viruses such as HSV-1, there are too little clinical data to draw any clear recommendations. On the other hand, clinical data is consolidating that CPC-containing mouthwashes can temporarily reduce the intraoral viral load and infectivity in SARS-CoV-2 positive individuals. Nevertheless, potential risks and side effects due to regular antiseptic use such as ecological effects or adaptation of bacteria need to be considered.
Conclusions
The use of preprocedural mouthwashes containing antiseptics can be recommended according to currently available data, but further studies are needed, particularly on the effects on other viruses besides SARS-CoV-2. When selecting a specific antiseptic, the biggest data basis currently exists for CHX, CPC, EO, or combinations thereof.
Clinical relevance
Preprocedural mouthwashes containing antiseptics can serve as part of a bundle of measures for protection of dental personnel despite some remaining ambiguities and in view of potential risks and side effects.
Top-30
Journals
|
1
2
3
|
|
|
Clinical Oral Investigations
3 publications, 13.64%
|
|
|
Journal of Dental Research
2 publications, 9.09%
|
|
|
Pediatric Reports
1 publication, 4.55%
|
|
|
Photochemical and Photobiological Sciences
1 publication, 4.55%
|
|
|
Oral Diseases
1 publication, 4.55%
|
|
|
Infection Control and Hospital Epidemiology
1 publication, 4.55%
|
|
|
Antibiotics
1 publication, 4.55%
|
|
|
PLoS ONE
1 publication, 4.55%
|
|
|
Journal of Dental Education
1 publication, 4.55%
|
|
|
Materials
1 publication, 4.55%
|
|
|
Journal of Evidence-Based Dental Practice
1 publication, 4.55%
|
|
|
Journal of Craniofacial Surgery
1 publication, 4.55%
|
|
|
Frontiers in Toxicology
1 publication, 4.55%
|
|
|
Pharmaceuticals
1 publication, 4.55%
|
|
|
American Journal of Infection Control
1 publication, 4.55%
|
|
|
Advances in Experimental Medicine and Biology
1 publication, 4.55%
|
|
|
World Academy of Sciences Journal
1 publication, 4.55%
|
|
|
Annals of African Medicine
1 publication, 4.55%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
5
6
|
|
|
Springer Nature
6 publications, 27.27%
|
|
|
MDPI
4 publications, 18.18%
|
|
|
Wiley
2 publications, 9.09%
|
|
|
Elsevier
2 publications, 9.09%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 9.09%
|
|
|
SAGE
2 publications, 9.09%
|
|
|
Cambridge University Press
1 publication, 4.55%
|
|
|
Public Library of Science (PLoS)
1 publication, 4.55%
|
|
|
Frontiers Media S.A.
1 publication, 4.55%
|
|
|
Spandidos Publications
1 publication, 4.55%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.